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Abstract 22 
ABSTRACT 23 
Study question: Is IL-1RA involved in the TLR 3-induced inhibition of trophoblast cells ?24 
adhesion to endometrial cells in vitro? 25 
 26 
Summary answer: IL-1RA mediates the TLR 3-ŝŶĚƵĐĞĚŝŶŚŝďŝƚŝŽŶŽĨƚƌŽƉŚŽďůĂƐƚĐĞůůƐ ?ĂĚŚĞƐŝŽŶ27 
to endometrial cells in vitro.  28 
 29 
What is known already: It is well documented that endometrial TLR 3 activation leads to 30 
impairment of trophoblast binding to endometrial cells in vitro.  IL-1 receptor antagonist (IL-31 
1RA) is known as an anti-implantation factor, as its injection significantly reduced 32 
implantation rates in mice by the effect on endometrial receptivity. 33 
 34 
Study design, size, duration: Poly I:C was used as TLR3 specific ligand and endometrial cells 35 
were either treated or not with Poly I:C (treated versus control) in vitro. IL-1RA was applied 36 
to block IL-1 signal transduction. IL-1RA was knocked down by Accell Human IL1RN siRNA. 37 
Flagellin was used to stimulate TLR 5. SP600125 (JNK) was applied to inhibit the MAPK 38 
pathway. BAY11 -7082 was used to inhibit the NF-ʃ ƉĂƚŚǁĂǇ. The experiments were 39 
performed in three replicates on three separate days. 40 
 41 
Participants/materials, setting, methods: An in vitro assay was developed using RL95-2 (an 42 
endometrial cell line) and JAr (a trophoblast cell line) cells. Initially, the production of IL-1RA 43 
in RL95-2 cells in response to TLR 3 activation was measured. To determine whether the TLR 44 
3-induced inhibition of trophoblast binding was mediated through IL-1RA: (i) we evaluated 45 
the effect of IL-1RA on the attachment of trophoblast cells to endometrial cells; (ii) we 46 
knocked down TLR3 induced IL-1RA gene expression by IL-1RA siRNA and evaluated 47 
trophoblast attachment to endometrial cells. Finally, to clarify through which pathway TLR 3-48 
induced inhibition of trophoblast binding occurs: (i) activation of NF-ʃ ĂŶĚ DW< ǁĂƐ49 
detected by transfecting the cells with secreted placental alkaline phosphatase (SEAP) 50 
reporter plasmids bearing promoter sequences for each transcription factor; (ii) the inhibitors 51 
for NF-ʃ ĂŶĚ DW< ǁĞƌĞ ƵƐĞĚ ƚŽ ďůŽĐŬ ƐŝŐŶaling; (iii) it was then investigated whether 52 
addition of these inhibitors could restore the TLR 3-induced impairment of trophoblast 53 
attachment to the endometrial cells.   54 
 55 
Main results and the role of chance: Our results showed that addition of Poly I:C to RL95-2 56 
cells significantly increased the production of IL-1RA (P < 0.05). Addition of human 57 
recombinant IL-1RA to RL95-2 cells remarkably decreased the adhesion rate of trophoblast 58 
cells to endometrial cells (P < 0.05). In addition, suppression of TLR3-induced IL-1RA gene 59 
expression in RL95-2 cells significantly restored trophoblast cells attachment to endometrial 60 
cells in the presence of Poly I:C (P < 0.05).  61 
Activation of MAPK was only induced by TLR 3 activation (P < 0.05). Of NF-kB and MAPK 62 
inhibitors ? ŽŶůǇ DW< ?Ɛ ŝŶŚŝďŝƚŽƌ ĐŽƵůĚ ĂĐŚŝĞǀĞ ƌĞƐƚŽƌĂƚŝŽŶ ŽĨ ƐƉŚĞƌŽŝĚ ĂĚŚĞƐŝŽŶ ƚŽ63 
endometrial cells (P < 0.05). 64 
 65 
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Limitations, reasons for caution: This study has been only done in vitro. Future in vivo studies 66 
will confirm our data. 67 
 68 
Wider implications of the findings: The findings of this study have a potential clinical 69 
application in introducing IL-1RA as one of the diagnostic infertility markers in the 70 
endometrium, which can affect the process of embryo adhesion at the time of implantation. 71 
Moreover, based on the novel data obtained in the current study, blocking and regulating the 72 
MAPK pathway by its inhibitors can be used as a new strategy to prevent and treat virus-73 
induced infertility cases in ART techniques. 74 
 75 
Study funding/competing interest(s): The authors have no conflict of interest to declare. 76 
 77 
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 79 
Introduction 80 
Despite many improvements in the assisted reproductive technologies (ART), implantation 81 
failure remains to be the major problem affecting the outcome of ART (Carver et al., 2003). 82 
Successful implantation relies on a high quality embryo, a receptive uterus and a series of 83 
tightly regulated interactions between the blastocyst and the endometrium. It has been 84 
shown that activation of the innate immune system in the female reproductive tract (FRT) in 85 
response to genital tract infections can affect this communication (Pellati et al., 2008, Dekel 86 
et al., 2010).  87 
 88 
The innate immune system in the FRT recognizes infectious microorganisms through 89 
pathogen recognition receptors (PRRs) such as the Toll-like receptors (TLRs) (Medzhitov and 90 
Janeway, 1997, Medzhitov and Janeway, 2002). To date, 10 members of the TLR family have 91 
been identified in humans (TLR 1 to 10), each of which recognizes and binds to a specific ligand 92 
(Beutler, 2004). Among the various TLR members, TLR 3 recognizes double-stranded RNA and 93 
plays an important role in the recognition of infectious viruses (Jorgenson et al., 2005, 94 
Schaefer et al., 2005, Yu and Levine, 2011). Upon detection of viruses by TLR3, an intracellular 95 
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cascade of molecular reactions is triggered, which leads to stimulation of the transcription 96 
factors nuclear factor (NF-ʃ) and mitogen-activated protein kinases (MAPK). Stimulation of 97 
MAPK would in turn activate the activating protein (AP)-1 composed of the proteins Jun and 98 
Fos. NF-kB and AP-1 are trans-located to the nucleus after activation, which results in 99 
induction of type 1 interferon (IFN), pro-inflammatory cytokines and chemokines (Matsumoto 100 
et al., 2011).  101 
 102 
There is a considerable body of evidence that TLR 3 is expressed in the primary uterine 103 
epithelial cells (Schaefer et al., 2005, Aflatoonian et al., 2007) and endometrial cell lines 104 
including ECC-1 (Schaefer et al., 2004), Ishikawa (Aboussahoud et al., 2010a) and RL95-2 105 
(Jorgenson et al., 2005). It has also been shown that TLR 3 recognizes viruses such as 106 
cytomegalovirus (CMV) and herpes simplex virus 1 (HSV-1) (Matsumoto et al., 2011), whose 107 
strong association with female infertility has been shown in many studies (el Borai et al., 1997, 108 
Medvedev et al., 2009, Yang et al., 1995). A significant association between infertility and HSV 109 
positive test was observed in women after failed in vitro fertilization (el Borai et al.,   1997). 110 
Similarly, it was found that seroprevalence and genital viral shedding of CMV were relatively 111 
high in infertile women (Yang et al 1995). Moreover, Inflammatory changes in reproductive 112 
organs in women with tubal-peritoneal infertility are determined by chronic herpesvirus 113 
infection (Medvedev et al., 2009). A significant association between CMV and HSV co-114 
infection (Rasti et al., 2015) and HSV-2 infection alone (Kalu et al., 2015, Kapranos and 115 
Kotronias, 2009) and occurrence of spontaneous abortion have been found. Fetal CMV 116 
infection is also linked to congenital abnormalities such as central nervous system anomalies, 117 
hydrops fetalis and oligohydramnios, as well as orofacial clefts (Weichert et al., 2010). 118 
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Similarly, fetal HSV infection is associated with extensive brain damage, hemorrhage, and 119 
cystic encephalomalacia (Vasileiadis et al., 2003).  120 
 121 
The effect of activation of some members of TLR family on embryo implantation has been 122 
shown before, with stimulation of TLR 2/6, 3 and 5 leading to impairment of trophoblast cells ? 123 
attachment to endometrial cells in vivo and in vitro (Aboussahoud et al., 2010b, Sanchez-124 
Lopez et al., 2014, Montazeri et al., 2015). Implantation failure is likely to be the major cause 125 
of infertility, thus deep insight into the molecular mechanisms that impact the process of 126 
embryo implantation in response to TLR 3 activation may provide new opportunities for 127 
improving the implantation rate in virus-induced infertility cases.  128 
 129 
Emerging evidence suggests that in addition to adequate hormonal priming, successful 130 
embryonic implantation relies on an appropriate interaction between cytokines produced 131 
and received by the blastocyst and endometrium (Cross et al., 1994). The interleukin-1 (IL-1) 132 
system seems to be relevant to the implantation process (Kauma et al., 1990). The IL-1 family 133 
consists of two agonists, IL-ůɲ ĂŶĚ />- ?ɴ(Dinarello, 1988), and an inhibitor, IL-1 receptor 134 
antagonist (IL-1RA). Two IL-1 receptors have been recognized: IL-1 receptor type I (IL-1R tI) 135 
(Sims et al., 1988) and IL-1 receptor typeII (IL-1R tII) (Horuk and McCubrey, 1989). The 136 
available information indicates that IL-1R tII is not functional and IL-1 signalling occurs 137 
exclusively via type I receptors (Sims et al., 1993). 138 
 139 
The presence of the IL-1 system in human endometrium (Tabibzadeh and Sun, 1992, Kauma 140 
et al., 1990, Simon et al., 1995, Simon et al., 1993a, Simon et al., 1993b), human embryos (De 141 
los Santos et al., 1996) and embryo-maternal interface (Simon et al., 1994) has been 142 
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previously demonstrated. Furthermore, it has been shown that IL-1 expression significantly 143 
increases at the late secretory phase, when the implantation of the embryo takes place 144 
(Simon et al., 1993a). These evidences suggest that IL-1 system may have a pivotal role in 145 
controlling and regulating the process of embryo implantation. IL-1RA can inhibit the binding 146 
ŽĨ/> ?ɲĂŶĚ/> ?ɴƚŽ IL-1R tI and its binding to the receptor does not result in signal transduction 147 
(Bankers-Fulbright et al., 1996). IL-1RA is also regarded as an anti-implantation factor and as 148 
Simon and colleagues have shown, IL-1RA prevented embryonic implantation in mice by ɲ ? ?149 
ɲǀĂŶĚɴ3 integrin subunits expression alteration on the endometrial epithelium (Simon et 150 
al., 1998).  151 
 152 
In the current investigation we hypothesized that IL-1RA mediated TLR 3-induced impairment 153 
of trophoblast adhesion to endometrial cells. We tested the validity of this hypothesis by 154 
measuring the production of IL-1RA in RL95-2 cells in response to TLR 3 activation and 155 
determined if IL-1RA has a negative effect on trophoblast adhesion to endometrial cells. 156 
Furthermore, we investigated if suppression of IL-1RA production by IL-1RA siRNA in RL95-2 157 
cells could restore the adhesion of JAr spheroids to the endometrial cells in the presence of 158 
Poly I:C. The results obtained confirmed IL-1RA involvement in TLR 3-induced reduction of 159 
trophoblast cells binding to endometrial cells. Finally we investigated the role of NF-ʃĂŶĚ160 
MAPK pathways activation in mediating TLR3-induced impairment of trophoblast cells 161 
adhesion to the endometrial cells. 162 
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 163 
Methodology 164 
Cell lines and cell culture 165 
RL95-2 was obtained from ATCC and was used to mimic endometrial cells. RL95-2 cells were 166 
cultured in T75 flasks at 37º C in DMEM (F12) HAM (Invitrogen, Paisley, UK), supplemented 167 
with penicillin (100 IU/ml) and streptomycin (100 Pg/ml) (Sigma, Poole, UK), 10% FCS 168 
(Invitrogen), 160 ng/ml Insulin (human recombinant insulin from Gibco (Invitrogen), catalog 169 
# 12585-014, and 2mM L-glutamine (Invitrogen), in 5% CO2 atmosphere until confluence was 170 
reached. The human choriocarcinoma cell line, JAr, was obtained from ATCC (catalog NO. 171 
HTB-144) and used as a model for trophoblast cells. JAr cells were grown in RPMI 1640 172 
(Sigma), supplemented with 10% FCS (Invitrogen), penicillin (100 IU/ml) and streptomycin 173 
(100 Pg/ml) (Sigma), and 2 mM L-glutamine (Invitrogen). At confluence, the cells were washed 174 
with Ca2+ and Mg2+ ĨƌĞĞƵůďĞĐĐŽ ?ƐƉŚŽƐƉŚĂƚĞ-buffered saline (DPBS; Sigma) and harvested 175 
using trypsin-EDTA (Invitrogen). The cells were then incubated for 3 min, pelleted by 176 
centrifugation at 300 g for 4 min and the supernatant was discarded. The cells were diluted 177 
with 3 ml of media and suspended with pipetting 5-6 times in order to ensure a homogenised 178 
solution.  179 
 180 
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Ligands and inhibitors  181 
Poly Inosinic Poly Cytidilic Acid (Poly I:C) (Invivogen, tlrl-pic, Toulouse, France), TLR 3 synthetic 182 
ligand  was used to stimulate TLR 3 (Alexopoulou et al., 2001). IL-1 receptor antagonist (IL-183 
1RA) (PeproTech, 200-01RA, London, UK) was applied to block IL-1 signal transduction. 184 
Flagellin was used to stimulate TLR 5 (Hayashi et al., 2001). SP600125 (JNK) was applied to 185 
inhibit the MAPK pathway (Bennett et al., 2001). BAY11 -7082 was used to inhibit the NF-ʃ186 
pathway (Saraiva et al., 2005). All ligands and inhibitors used in the current study were 187 
obtained from Invivogen Company (Invivogen, Toulouse, France). 188 
 189 
 190 
In vitro human implantation assay 191 
The RL95-2 cells were cultured in T75 flasks until 100% confluence, cells were then harvested 192 
using trypsin-EDTA. The cells were counted and 3x10 ? endometrial cells were cultured in each 193 
well of a 12-well plate. They were incubated at 37°C and 5% of CO2 for 4 days until confluence. 194 
The media were replaced every second day. 195 
 196 
To create spheroids from JAr cells monolayers, 10 ? cells/ml were counted with a 197 
Haemocytometer, and cultured in 5 ml of RPMI 1640 media in 60 × 15 mm Petridishes 198 
(CellStar tissue culture dishes, Greiner Bio-One, GmbH/Germany) in a humid atmosphere 199 
containing 5% COA? at 37°C on a gyratory shaker (IKA MTS 2/4, Staufen, Germany), set at 300 200 
rpm for 24 h. 201 
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 202 
Once the JAr spheroids were formed on the shaker, they were gently transferred onto each 203 
well of confluent RL95-2s in 12-well plates, and the co-culture was maintained in DMEM-F12 204 
HAM, with supplements as mentioned above and incubated for 1 h at 37°C. The images of JAr 205 
spheroids and RL95-2s co-culture were captured by a Nikon DS-Fi1 camera (Nikon, Kingston 206 
Upon Thames, UK) connected to an inverted CKX41 fluorescent microscope (OLYMPUS, 207 
Tokyo, Japan). 208 
 209 
Non-adherent spheroids were removed from the monolayer using an automatic horizontal 210 
shaker (Labman Automation LTD) to detach loosely bound or unbound spheroids. In brief, 211 
once the trophoblast spheroids were co-cultured with endometrial cells, the number of 212 
spheroids was counted under the microscope and each plate was placed on a shaker, which 213 
was set at 200 rpm for 4 min. The cells were washed with DPBS twice and then the number 214 
of attached spheroids was counted under the microscope. The results were expressed as the 215 
percentage of spheroids attached from the total number of spheroids used to initiate the co-216 
incubation experiments. All the experiments were performed in three replicates.  217 
 218 
RNA isolation and cDNA synthesis 219 
For endometrial cell lines genomic studies, RL95-2 cells were washed with DPBS without Ca2+ 220 
and Mg2+ and one milliliter of TRIreagent (Sigma) was added onto the flask. Thereafter total 221 
RNA from cells was extracted following a standard protocol supplied by the manufacturer. 222 
Total RNA obtained from RL95-2 cells was treated three times with DNase I (DNA-freeTM, 223 
Ambion Austin, TX, USA) to remove genomic DNA contamination from the samples. First 224 
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strand cDNA synthesis was performed using oligo dT primers (Metabion, Martinsried, 225 
Germany) and reverse transcription by Super- Script II (200 U/µl; Invitrogen). Negative 226 
controls were prepared without inclusion of the enzyme (non-reverse transcribed controls, 227 
RT controls).  228 
 229 
 Quantitative Real Time PCR (QPCR) 230 
 231 
The IL-1RA forward primer was 25 bp, with a G/C content of 48 % and a similar melting 232 
temperature (Tm) for forward and reverse primers (59.9°C). The IL-1RA reverse primer was 233 
22 bp, with a G/C content of 59 %. The IL-1RA ƉƌŝŵĞƌ ƐĞƋƵĞŶĐĞ ǁĂƐ  ? ?-234 
CCAGCAAGATGCAAGCCTTCAGAAT- ? ? ĨŽƌ ƚŚĞ ĨŽƌǁĂƌĚ ƐĞƋƵĞŶĐĞ ĂŶĚ  ? ?-235 
CCAGACTTGACACAGGACAGGC- ? ?ĨŽƌƚŚĞƌĞǀĞƌƐĞƐequence, and product size was 199 bp. The 236 
efficiency of the IL-1RA primer was verified by quantitative real-time PCR (QPCR) (Data not 237 
shown). The variation of the quantification cycle number (Cq) was estimated during the 238 
exponential phase. A standard curve was generated using serial dilutions of the samples of 239 
cDNA (1, 1/5, 1/15, 1/45, 1/135 and 1/405) and plotted using the logarithm of the cDNA 240 
dilution versus the average Cq of three replicates.  241 
 242 
An efficiency of 80 to 120 % for each set of primers was considered acceptable for further 243 
analysis of gene expression. 244 
 245 
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Quantitative Real-Time PCR (QPCR) and gel analysis 246 
QPCR was carried out with the cDNA prepared from RL95-2 cells as described. For 247 
ŶŽƌŵĂůŝǌĂƚŝŽŶ ƉƵƌƉŽƐĞƐ ? ĞǆƉƌĞƐƐŝŽŶ ŽĨ ƚŚĞ ƌĞĨĞƌĞŶĐĞ ŐĞŶĞƐ ɴ-actin and B2M were also 248 
ƋƵĂŶƚŝĨŝĞĚ ?dŚĞƐĞƋƵĞŶĐĞŽĨƚŚĞŝƌƉƌŝŵĞƌƐǁĂƐĂƐĨŽůůŽǁƐ Pɴ-ĂĐƚŝŶĨŽƌǁĂƌĚƐĞƋƵĞŶĐĞǁĂƐ ? ?-249 
CAAGATCATTGCTCCTCCTG- ? ?ĂŶĚƌĞǀĞƌƐĞƐĞƋƵĞŶĐĞǁĂƐ ? ?-ATCCACATCTGCTGGAAGG- ? ? ?ĂŶĚ250 
product size was 152 bp (Sanchez Lopez et al., 2014b).  ?D ĨŽƌǁĂƌĚ ƐĞƋƵĞŶĐĞ ǁĂƐ  ? ?-251 
TATGCCTGCCGTGTGAACCA- ? ? ĂŶĚ ƌĞǀĞƌƐĞ ƐĞƋƵĞŶĐĞ ǁĂƐ  ? ?-GCGGCATCTTCAAACCTCCA- ? ? ?252 
and product size was 98 bp (Sanchez Lopez et al., 2014b). SYBR Green Jump Start (Sigma) 253 
master mix (containing 10µl SYBR Green, 7µl H2O, 1µl of test or reference gene primers and 254 
1µl cDNA) was added to each well of PCR plate and amplification was performed under the 255 
following conditions: 40 cycles of 95ƕ for 30 s, 62ƕ for 30 s and 72ƕ for 30 s. All experiments 256 
included RT controls and negative controls (no cDNA). QPCR was performed using Mx3005P 257 
QPCR (Stratagene, Waldbronn, Germany) and results were analysed using MxPro QPCR 258 
software version 4.01. The amplified QPCR products were sequenced to confirm the identity 259 
of the amplified product. The size of the amplicon was confirmed by electrophoresis in a 1% 260 
agarose gel  261 
 262 
The QPCR data were analysed using the ȴȴƋmethod. The results were expressed as mean ± 263 
^D ?^ƚĂƚŝƐƚŝĐĂůĂŶĂůǇƐŝƐǁĂƐƉĞƌĨŽƌŵĞĚďǇƵƐŝŶŐEKsǁŝƚŚdƵŬĞǇ ?ƐŵƵůƚŝƉůĞĐŽŵƉĂƌŝƐŽŶ264 
test. P < 0.05 was considered significant.  265 
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Enzyme-linked immunosorbent assay (ELISA)  266 
The concentration of IL-1RA was determined in culture supernatants with the commercially 267 
available IL-1RA Development ELISA kit (PEPROTECH, London, UK). The ELISA was performed 268 
ĂĐĐŽƌĚŝŶŐƚŽƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐǁŝƚŚ ? ? ?A?ůŽĨĐĞůů-free supernatant.  269 
 270 
IL-1RA gene expression Knock down in RL95-2 cells 271 
IL-1RA was knocked down by Accell Human IL1RN siRNA (SMARTpool) (ThermoScientific, 272 
Massachusetts, Waltham). In addition, the efficiency of siRNA transfection was assessed using 273 
Accell Green Non-targeting siRNA (ThermoScientific, D-001950-01-05, Massachusetts, 274 
Waltham) and it was used as negative control (Data not shown). Briefly, IL-1RA siRNA was 275 
diluted with Accell Delivery Media (ThermoScientific, Massachusetts, Waltham) to reach a 276 
concentration of 1 µM. The growth media were removed from the cells and 100 µl of delivery 277 
mix was added to each well of 96-well plate. RL95-2 cells were incubated with IL-1RA siRNA 278 
at 37°C with 5 % CO2 for 72 h. The efficiency of IL-1RA siRNA in suppressing IL- ?Z ?Ɛ279 
production was measured at both gene and protein levels (Data not shown). The mRNA of 280 
knock down cells was assessed by QPCR as described.  The sample of knock down cells was 281 
assessed by IL-1RA ELISA kit as described. 282 
 283 
Transfection of RL95-2 cells with SEAP plasmids containing NF-ʃ284 
and AP-1 binding regions 285 
The RL95-2 cells were grown in 24-well plates (2x104 cells) until 70% confluency and 286 
transiently transfected with pNifty2-SEAP for NF-ʃĞǆƉƌĞƐƐŝŽŶ ?/ŶǀŝǀŽ'ĞŶ ?dŽůŽƵƐĞ ?&ƌĂŶĐĞ ?287 
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or the pNifty3-SEAP for AP-1 expression using X-tremeGENE HP DNA transfection reagent 288 
(Roche). Briefly, the media in each well of the 24-well plate were replaced with fresh 289 
supplemented media. The mix was prepared using a 1:3 ratio plasmid  ? transfection reagent 290 
ŝŶ  ? ? ʅů ŽĨ ƐĞƌƵŵ-free DMEM/F-12. Supernatant samples were collected and secreted 291 
placental alkaline phosphatase (SEAP) was detected using the Phospha->ŝŐŚƚ ?^WZĞƉŽƌƚĞƌ292 
gene assay system (Life Technologies, Applied Biosystems, Paisley, UK) according to the 293 
ŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐƉƌŽƚŽĐŽů. 294 
 295 
Viability assessment of endometrial cells 296 
In order to check the viability of RL95-2 cells treated with either recombinant human IL-1RA 297 
or IL-1RA siRNA, RL95-2 cells were grown in 96-well plates until 100 % confluence. The media 298 
were replaced with serum free media before they were either treated or not with IL-1RA or 299 
IL-1RA siRNA. The cells were then harvested using trypsin-EDTA and ĐŽůůĞĐƚĞĚ ŝŶ  ? ? ?ʅůŽĨ300 
media and pelleted by centrifuging at 300 g for 5 min. The cells were then resuspended in 200 301 
ʅů ŽĨ PBS and divided in two 5 ml cytometry tubes. One sample was used as an 302 
autofluorescence control sample and the other was used for staining ǁŝƚŚ ?ʅDƉƌŽƉŝĚŝƵŵ303 
iodide (PI; Life technologies, Paisley, UK) and captured immediately. The samples were read 304 
in a FACSCalibur cytometer (Rasti et al.) capturing 1x104 events and the percentage of PI 305 
positive events (dead cells) was registered. The results were expressed as percentage of live 306 
cells and were compared using a one-way ANOVA, with p < 0.05 considered significant. 307 
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 308 
Experimental design 309 
The effect of TLR 3 activation on the production of IL-1RA in RL95-2 310 
cells 311 
To determine whether TLR 3 activation in RL95-2 cells could alter IL-1RA production at the 312 
gene and protein level, RL95-2 cells were cultured in 12-well plates and the media replaced 313 
with serum-free media before they were either activated or not with Poly I:C at a 314 
concentration of 10 µg/ml. IL-1RA gene expression was evaluated by QPCR at 2 and 4 h post 315 
TLR3 activation. IL-1RA protein concentration was determined at 1, 2, 4, 6, 8 and 24 h post-316 
TLR3 activation by ELISA as described. 317 
 318 
The effect of IL-1RA on binding of trophoblast cells to endometrial 319 
cells 320 
In order to determine the influence of the treatment of RL95-2 cells with IL-1RA on the 321 
number of trophoblast cells binding to the endometrial cells, RL95-2 cells were cultured in 24-322 
well plates and the media replaced with serum-free media before they were either activated 323 
or not with IL-1RA at various concentrations (5, 10, 20 and 40 ng/ml) for 4 h. Thirty JAr 324 
spheroids were then gently delivered to the endometrial cells in each well and co-incubated 325 
for 1 h. Adhesion was assessed as described. In parallel, the viability of RL95-2 cells was 326 
assessed by Propidium Iodide staining as described, to exclude detrimental effects of IL-1RA 327 
on endometrial cells viability. 328 
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 329 
To clarify whether the detected response to treatment of RL95-2 cells with Poly I:C was 330 
mediated through IL-1RA, IL-1RA expression was knocked down or not in RL95-2 cells using 331 
IL-1RA siRNA or IL-1RA negative control siRNA, respectively. RL95-2 cells were treated or not 332 
with Poly I:C  (10 ʅŐ ?ŵů ?for 4 h, 30 JAr spheroids were then delivered onto the RL95-2 333 
monolayer and co-cultured for 1 h. Adhesion was assessed as described. 334 
 335 
Activation of NF-ʃ ĂŶĚ W-1 as a result of endometrial TLR 336 
activation  337 
The RL95-2 cells were transfected with either the pNifty2 (NF-ʃ ?or pNifty3 (AP-1) plasmids. 338 
On the next day, the culture media was replaced with serum-free DMEM/F-12 and the cells 339 
were stimulated with 100 ng/ml of flagellin (TLR 5) oƌ ? ?ʅŐ ?ŵůŽĨWŽůǇ/ P ?d>Z ? ?ĨŽƌ ? h. The 340 
supernatants were collected and the SEAP was measured with QUANTI-blueTM (InvivoGen). 341 
Data were reported as the fold induction of SEAP activity over the non-stimulated control. 342 
Determining the effect of NF-ʃ ĂŶĚ W-1 on the adhesion of JAr 343 
spheroids to the endometrial cells 344 
To assess whether NF-ʃ or AP-1 pathways could mediate TLR 3-induced impairment of 345 
trophoblast adhesion to endometrial cells, the RL95-2 cells were pre-treated or not with the 346 
NF-ʃĂŶĚW-1 inhibitors. The activation of NF-ʃĂŶĚDW<ƉĂƚŚǁĂǇƐǁĂƐŝŶŚŝďŝƚĞĚďǇpre-347 
treating RL95-2 cells with z ? ?  ? ? ? ʅD ? ĂŶĚ ^W ? ? ? ? ? ?  ? ? ? ʅD ?, respectively, for 1 h. 348 
Thereafter, the RL95-2 were either stimulated or not with 10 µg/ml of Poly I:C for 4 h. 30 JAr 349 
spheroids were then gently delivered into each well and co-incubated for 1 h at 37°C. 350 
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Adhesion was assessed as described. The activity of the inhibitors had been validated before 351 
(data not shown) and only their functional dose was applied in this set of experiments. 352 
 353 
Statistical Analysis 354 
The results were expressed as mean ± SEM. Statistical analysis was performed using ANOVA 355 
(Statistica; Statsoft UK, Letchworth, UK) with Fischer's multiple comparison test. P < 0.05 was 356 
considered to be significant. All the experiments represented here were performed in three 357 
replicates in different days.  358 
 359 
Results 360 
JAr spheroids attach and bind to endometrial cells. 361 
After one hour of the Jar spheroids coincubation with the endometrial cells, the JAr spheroids 362 
attached and bound firmly to RL95-2 cells (Fig. 1). 363 
 364 
Production of IL-1RA was increased in RL95-2 cells in response to 365 
Poly I:C. 366 
As shown in Fig. 2A, addition of Poly I:C to RL95-2 cells significantly increased the gene 367 
expression of IL-1RA. This effect was observed as soon as 2 h of Poly I:C treatment. A similar 368 
effect was observed in the protein level of IL-1RA (Fig. 2B, where there was a clear significant 369 
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increase in the IL-1RA levels in response to Poly I:C even after 1 h, despite a slight but 370 
significant decline after 4 h. 371 
 372 
Addition of IL-1RA to RL95-2 cells significantly decreased percentage 373 
of attachment of JAr spheroids to endometrial cells.  374 
The percentage of attachment of JAr spheroids to endometrial cells was significantly 375 
suppressed in the IL-1RA treated group compared to control in a dose-dependent manner 376 
(Fig. 3A). Reduction of IL-1RA gene expression significantly restored the percentage of 377 
attachment of JAr spheroids to endometrial cells in the presence of Poly I:C (Fig. 3B). As shown 378 
in Fig. 3C and 3D, recombinant human IL-1RA and IL-1RA siRNA did not have any effect on the 379 
viability of RL95-2 cells. 380 
 381 
TLR 3 stimulation induced MAPK pathway activity in endometrial 382 
cells  383 
The treatment of the endometrial cells with flagellin was able to significantly increase NF-ʃ384 
activity after 4 h (P < 0.05), whereas Poly I:C was unable to increase this activation (Fig. 4A). 385 
The treatment of the endometrial cells with Poly I:C was able to significantly induce the 386 
activity of AP-1 after 4 h (P < 0.05) compared with the non-stimulated control (Fig. 4). 387 
 388 
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Inhibition of the MAPK JNK pathway affected the binding of the 389 
trophoblast spheroids to the endometrial cells 390 
The pre-treatment of the RL95-2 cells with Bay11-7082 was unable to significantly restore the 391 
binding of trophoblast cells to endometrial cells in the presence of Poly I:C (Fig. 5). In contrast, 392 
addition of SP600125 to endometrial cells significantly recovered the percentage of 393 
trophoblast cells attached to RL95-2 cells (Fig. 5).  394 
 395 
Discussion 396 
Different factors are required to control the process of implantation, including hormones, 397 
cytokines, adhesion molecules and growth factors (Singh et al., 2011). In humans and 398 
primates, implantation is known to resemble an inflammatory type response. Different 399 
cytokines has been identified in the human endometrium, such as IL-1, whose production was 400 
conceived to regulate and control the functions of endometrial cells during the menstrual 401 
cycle (Tabibzadeh and Sun, 1992, Tabibzadeh, 1994). IL-1 is a key regulator of the 402 
inflammatory response and plays a crucial role in implantation (Bankers-Fulbright et al., 403 
1996). It was shown that IL- ?ɴǁĂƐĞǆƉƌĞƐƐĞĚŝŶŚƵŵĂŶĞŶĚŽŵĞƚƌŝƵŵ(Simon et al., 1993a, 404 
Tabibzadeh and Sun, 1992, Kauma et al., 1990) throughout the menstrual cycle and its 405 
concentration progressively increased in the secretory phase in comparison to the 406 
proliferative phase. This rise was coordinated with the increase in the messenger levels of IL-407 
1 receptor, where IL-1R tI mRNA levels increased significantly in the luteal phase versus the 408 
follicular phase (Simon et al., 1993a, Simon et al., 1993b).  409 
 410 
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IL-1RA is also present in the human endometrial epithelial cells (EECs) throughout the entire 411 
menstrual cycle (Tabibzadeh and Sun, 1992). IL-1RA concentration increases significantly 412 
during the follicular phase versus the early and mid-to-late luteal phase (Simon et al., 1995). 413 
Moreover, the IL-1 system was found in the human embryo (De los Santos et al., 1996), and 414 
at the maternal-embryonic interface (Simon et al., 1994).  Embryonic IL-1 release occurred 415 
only when embryos were co-cultured with human EECs (Spandorfer et al.). It is noteworthy 416 
that IL-1 produced from human embryos can regulate and increase endometrial receptivity in 417 
 ĐĞůůƐ ďǇ ŝŶĐƌĞĂƐŝŶŐ ƚŚĞ ĞǆƉƌĞƐƐŝŽŶ ŽĨ ɲ ? ? ɲ ? ĂŶĚɴ ?integrins (Simon et al., 1997). 418 
Moreover, successful implantation after in vitro fertilisation has been correlated to high 419 
concentrations of both IL- ?ɲĂŶĚ/>- ?ɴŝŶƚŚĞĐƵůƚƵƌĞŵĞĚŝƵŵŽĨŚƵŵĂŶĞŵďƌǇŽƐ(Karagouni 420 
et al., 1998). On the other hand, it is well-established that IL-1RA can suppress embryo 421 
implantation in mice, by decreasing endometrial receptivity (Simon et al., 1998). Accordingly, 422 
the assumption that IL-1RA serves as an anti-implantation factor led us to search for the 423 
possibility that TLR 3-induced impairment of trophoblast adhesion to endometrial cells could 424 
be mediated through IL-1RA. Hence, we investigated whether TLR 3 activation in RL95-2 cells 425 
could alter the gene expression of IL-1RA.  426 
 427 
IL- ?Z ?ƐŐĞŶĞĞǆƉƌĞƐƐŝŽŶǁĂƐŵĞĂƐƵƌĞĚďǇƋWZĂŶĚall the steps including RNA extraction, 428 
cDNA synthesis and qPCR were performed in accordance to Minimum Information for 429 
Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines (Bustin et al., 2009). 430 
Our results showed that the gene expression of IL-1RA was increased significantly even after 431 
2 h of Poly I:C administration. These data were confirmed by IL-1RA ELISA at the protein level. 432 
This is consistent with the findings of Lee and colleagues, who showed that the production of 433 
IL-1RA was significantly increased in response to Poly I:C in microglial cells (Lee et al., 2007, 434 
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Rabehi et al., 2001). In addition, activation of other TLR members such as TLR 4 by LPS has 435 
been shown to increase production of IL-1RA in monocytes (Rabehi et al., 2001, Rehani et al., 436 
2009). Although these findings clearly document the stimulatory effect of TLR activation on 437 
IL-1RA production, little is known regarding the cellular mechanisms regulating the 438 
production of IL-1RA in response to TLR activation. Involvement of MAPK pathway in IL-1RA 439 
production has been shown in many studies, where the blocking of p38 and ERK, as subunits 440 
of MAPKs, dramatically decreased the production of IL-1RA upon LPS stimulation (Rabehi et 441 
al., 2001). This is in agreement with the findings of Rehani et al., in which it was shown that 442 
ERK pathway activity is required to augment IL-1RA production upon TLR 4 activation in 443 
monocytes (Rehani et al., 2009). Moreover, we were able to show that MAPK pathway activity 444 
was significantly increased in endometrial cells in response to Poly I:C. In the same line of 445 
evidence it was shown that TLR 3 activation by Poly I:C significantly induced MAPK pathway 446 
activity by increasing the production of AP-1 in Fibroblast-like synoviocytes (FLS) (Yoshizawa 447 
et al., 2008). Thus, it seems reasonable that induced MAPK pathway activity upon TLR 3 448 
stimulation can lead to the observed increased levels of IL-1RA production in response to TLR 449 
3 activation. Further investigations are needed to demonstrate this possibility. 450 
 451 
Addition of IL-1RA to RL95-2 cells reduced the adhesion of trophoblast cells to endometrial 452 
cells in a dose-dependent manner. Moreover, the inhibitory effect of Poly I:C on spheroid 453 
binding was restored consequent to knock down of IL-1RA expression. This data strongly 454 
indicates that the observed Poly I:C effect was mediated by IL-1RA. This is consistent with the 455 
previous studies, where it was shown that IL-1RA injection in mice prevented embryonic 456 
implantation through direct effect on the transformation of plasma membrane of epithelial 457 
endometrial cells at the time of implantation (Simon et al., 1998). Moreover, the concept that 458 
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IL-1RA could have inhibitory effect on embryo adhesion at the time of implantation is further 459 
supported by the findings of Simon and Frances (1995), in which they showed that IL-1RA 460 
staining significantly decreased towards the secretory phase, which corresponds to the 461 
 “ǁŝŶĚŽǁ ŽĨ ŝŵƉůĂŶƚĂƚŝŽŶ ?(Simon et al., 1995). Together with the experimental data 462 
presented here, one can speculate that IL-1RA can lead to inhibition of trophoblast cells 463 
binding to endometrial cells in vivo and in vitro, but the mechanisms through which this 464 
alteration happens remain unclear. The current study investigated the effect of IL-1RA on 465 
endometrial cells only and further investigation is needed to establish the role of IL-1 system 466 
in JAr cells/spheroids and to understand the potential effects of IL-1RA on these cells as well. 467 
 468 
After binding to Poly I:C, TLR 3 can activate both the NF-kB and MAPK signaling pathways. In 469 
order to clarify the signaling pathways through which TLR 3 activation inhibit trophoblast 470 
binding to endometrial cells, both NF-kB and MAPK pathways were blocked using specific 471 
inhibitors. Inhibition of NF-ʃ ĂĐƚŝǀŝƚǇ ǁĂƐƵŶĂďůĞ ƚŽ ƌĞƐƚŽƌĞ ƚƌŽƉŚŽďůĂƐƚ ĐĞůůƐ ĂĚŚĞƐŝŽŶ ƚŽ472 
endometrial cells. This is in contrast with the previous finding where it was shown that Bay11-473 
7082 was able to restore the flagellin-induced impairment of the attachment of trophoblasts 474 
cells to the endometrial Ishikawa 3H-12 cells (Caballero et al., 2013). It is possible that in our 475 
model the TLR 3-mediated reduction of trophoblast spheroid adhesion to the endometrial 476 
cells is cell-specific and could signal through a different route such as MAPK pathway. 477 
Treatment of RL95-2 cells with the MAPK JNK inhibitor SP600125 recovered the spheroid 478 
adhesion to endometrial cells in the presence of Poly I:C. This data confirmed the inhibitory 479 
role of MAPK JNK pathway on trophoblast spheroid adhesion to endometrial cells in RL95-2 480 
cells. Hence, it might be logical to believe that MAPK pathway could mediate the TLR 3-481 
induced production of IL- ?Z ? ǁŚŝĐŚ ŝŶ ƚƵƌŶ ůĞĂĚƐ ƚŽ ƚŚĞ ŝŵƉĂŝƌŵĞŶƚŽĨ ƚƌŽƉŚŽďůĂƐƚ ĐĞůůƐ ?482 
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attachment to endometria cells (Fig 6). Further investigation is required to establish the role 483 
of MAPK pathway in this system. In this regard, blocking MAPK pathway and investigating its 484 
effect on the Poly I:C-induced IL-1RA production would be worth trying. The involvement of 485 
MAPK pathway in the TLR 3-mediated ŝŶŚŝďŝƚŝŽŶŽĨƚƌŽƉŚŽďůĂƐƚĐĞůůƐ ?ĂĚŚĞƐŝŽŶƚŽĞŶĚŽŵĞƚƌŝĂů486 
cells has been shown before in our previous study (Montazeri et al., 2015), where it was found 487 
that MAPK mediated TLR 3-induced impairment of actin polymerization, cluster of 488 
differentiation (CD98) ĂŶĚ ɴ ? ŝŶƚĞŐƌŝŶ ĞǆƉƌĞƐƐŝŽŶ, which may result in impairment of 489 
trophoblast adhesion.  490 
 491 
Since IL-1 is such a potent inflammatory cytokine, it is critical that its biological effects be 492 
precisely controlled. In this regard, IL-1RA acts as a regulator of IL-1 biological effects and 493 
when it binds to IL-1R tI on the cell surface, it blocks the IL-1 signal transduction (Bankers-494 
Fulbright et al., 1996). The balance of the IL-1/IL-1RA levels is crucial. Indeed, it is well 495 
documented that the relative levels of IL-1 and the endogenous IL-1RA correlate with the 496 
pathogenesis of many diseases and an excess amount of IL-1, for instance, can develop 497 
inflammatory and autoimmune diseases such as diabetes and rheumatoid arthritis (Bankers-498 
Fulbright et al., 1996, Arend, 2002). In addition, increased levels of IL-1RA have been found in 499 
the circulation of patients with a variety of inflammatory, infectious, and post-surgical 500 
conditions (Arend et al., 1998). This indicates the importance of hepatic production of IL-1RA 501 
as an acute phase protein, which diffuses into the tissues and influences the local ratio of IL-502 
1RA to IL-1 (Gabay et al., 1997). Accordingly, treatment of these diseases has been carried out 503 
by injection of recombinant IL-1RA protein or using gene therapy approaches (Arend, 2002). 504 
An appropriate ratio of IL-1 to IL-1RA is also pivotal to initiate and maintain successful 505 
implantation at the local fetal-maternal interface (Huang et al., 2001), and as shown in mice 506 
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and the current study, increased levels of IL-1RA can interfere with the process of trophoblast 507 
cells binding to endometrial cells and may result in implantation failure. This can be due to 508 
the fact that in the presence of excess amount of IL-1RA, the stimulatory effect of IL- ?ɴŽŶ509 
endometrial receptivity (Simon et al., 1997) is blocked and as a result of that, the adhesion of 510 
embryo to endometrial cells is impaired. In the same line of evidence, the fact that IL-1RA 511 
expression significantly decreased in the secretory phase (Simon et al., 1995), when embryo 512 
implantation is taking place suggests the existence of specific inhibition of IL-1RA production 513 
at the time of implantation, which facilitates IL-1 pre-implantation actions on endometrial 514 
receptivity. The window of implantation is the time frame when the endometrium changes 515 
for the arrival of the embryo. For this reason, a safe environment should be guaranteed. If 516 
the innate immune system is activated at this time, the uterine tissue is able to respond 517 
actively. On one hand, the response will defend the maternal tract from a potential infection, 518 
but on the other hand this defense strategy might result in adversely affecting implantation 519 
of the embryo.  520 
 521 
Approximately 35% of infertile women are afflicted with post-inflammatory changes of the 522 
reproductive organs, most of which result from infection in the FRT (Novy et al., 2008). 523 
Although, no data is available to support what proportion of these infertility cases are virus-524 
induced. As mentioned before, a strong association between HSV and CMV infection and 525 
female infertility, spontaneous abortion and congenital defects has been found (el Borai et 526 
al., 1997, Medvedev et al., 2009, Yang et al., 1995, Kalu et al., 2015, Rasti et al., 2015, 527 
Vasileiadis et al., 2003, Weichert et al., 2010). Both HSV and CMV infection recognition with 528 
TLR 3 has been shown before (Matsumoto et al., 2011). This evidence in conjunction with the 529 
ĚĂƚĂ ŽďƚĂŝŶĞĚ ĨƌŽŵ ŽƵƌ ǁŽƌŬ ƚŚĂƚ ŵĂƚĞƌŶĂů d>Z ? ĂĐƚŝǀĂƚŝŽŶŝŵƉĂŝƌƐ ƚƌŽƉŚŽďůĂƐƚ ĐĞůůƐ ?530 
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adhesion to endometrial cells, show the possibility of the involvement of maternal HSV and 531 
CMV infection in the failure of embryo implantation.  Although, no concrete evidence may 532 
exist to pinpoint the association between HSV and CMV infection and embryo implantation 533 
failure in human,  the effect of CMV infection on embryo implantation has been determined 534 
in mice, where the inoculation of maternal CMV significantly reduced embryo implantation 535 
rates (Neighbour, 1976). Our findings raise the possibility of clinical significance of screening 536 
and treatment for viral infections among pre-pregnant women to identify and treat the high-537 
risk population for virus-induced implantation failure. This will improve not only the embryo 538 
implantation rate in ART techniques but also will deepen our understanding of different 539 
factors involved in endometrial receptivity. 540 
 541 
Many factors produced by the endometrium during the window of implantation have been 542 
proposed as molecular markers of endometrial receptivity, such as LIF and mucin 1 (Sharkey 543 
and Smith, 2003), but little attention has been paid to their application in the treatment of 544 
infertility. In the current study the discovery that increased levels of IL-1RA upon TLR 3 545 
activation directly impair trophoblast adhesion to endometrial cells could be used as a 546 
significant diagnostic and therapeutic tool for the treatment of viral-induced infertility cases.  547 
 548 
To conclude here, we report our findings that IL-1RA mediated TLR 3-induced impairment of 549 
trophoblast cells adhesion to endometrial cells in vitro. This finding demonstrates the 550 
potential clinical application of IL-1RA as an infertility diagnostic marker. Moreover, based on 551 
the novel data obtained in the current study, blocking and regulating the MAPK pathway by 552 
its inhibitors can be used as a new strategy to prevent and treat virus-induced infertility cases 553 
in ART techniques. 554 
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 740 
Figure legends 741 
  742 
 743 
Figure 1. JAr spheroids attach and adhere to endometrial cells. 744 
Once the JAr spheroids were formed on the shaker, they were gently transferred onto each 745 
well of confluent RL95-2s in 12-well plates, and the co-culture was maintained in DMEM-F12 746 
HAM and incubated for 1 h at 37°C. The images of JAr spheroids and RL95-2s co-culture were 747 
then captured by an inverted fluorescent microscope. 748 
  749 
Figure 2. The effect of TLR 3 stimulation on IL-1RA production in RL95-2 cells. 750 
RL95-2 cells were treated with 10 Pg/ml of Poly I:C for various time points. Firstly, the gene 751 
expression of IL-1RA was assessed by QPCR (A). Secondly, the IL-1RA production at the protein 752 
level was investigated by IL-1RA ELISA (B). The experiments were performed in three 753 
replicates on three separate days. The data are the average of three independent 754 
experiments. The results were presented as the mean ± SEM. ANOVA was used to compare 755 
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the gene expression and production of IL-1RA at each time interval. Different letters denote 756 
significant differences. P < 0.05 was considered to be significant. 757 
 758 
Figure 3. The effect of IL-1RA on trophoblast cells binding to endometrial cells. 759 
RL95-2 cells were treated with IL-1RA at various concentrations (0, 5, 10, 20 and 40 ng/ml) for 760 
4 h.  The effect of IL-1RA was then investigated on the trophoblast adhesion to endometrial 761 
cells (A). RL95-2 cells were then transfected by IL-1RA siRNA at a concentration of 1 µM for 762 
72 h. They were then treated by Poly I:C (10 µg/ml) for 4 h and the influence of IL-1RA knock 763 
down on trophoblast binding to RL95-2 cells was assessed (B). The viability of RL95-2 cells was 764 
determined after their treatment with different concentrations of IL-1RA (0, 5, 10 and 20 and 765 
40 ng/ml) (C). In addition, the effect of addition of IL-1RA siRNA to RL95-2 cells on the viability 766 
of endometrial cells was assessed (D). The experiments were performed in three replicates 767 
on three separate days. The data are the average of three independent experiments. The 768 
results were presented as the mean ± SEM. ANOVA was used to compare the percentage of 769 
attached JAr spheroids to endometrial cells in each group. Different letters denote significant 770 
differences. P < 0.05 was considered to be significant. 771 
 772 
Figure 4. Activation of NF-ʃĂŶĚW-1 in RL95-2 cells after TLR stimulation.  773 
RL95-2 cells were transfected with the pNifty2 (NF-ʃ ?ĂŶĚƉEŝĨƚǇ ? ?W-1) plasmids containing 774 
a secreted alkaline phosphatase (SEAP) reporter. The cells were stimulated with the ligands 775 
ĨŽƌd>Z ? ? ? ? ?ŶŐ ?ŵů&ůĂŐĞůůŝŶ ?ĂŶĚd>Z ? ? ? ?ʅŐ ?ŵůWŽůǇ/ P ?ĨŽƌ ?Ś ?^WƉƌŽĚƵĐƚŝŽŶwas 776 
measured and results represented as fold of NF-ʃ ĂŶĚ W-1 activation with untreated 777 
control. The experiments were performed in three replicates on three separate days. The data 778 
are the average of three independent experiments. The results were presented as the mean 779 
± SEM. ANOVA was used to compare the fold of NF-ʃĂŶĚW-1 production in each group. 780 
Different letters denote significant differences. P < 0.05 was considered to be significant. 781 
 782 
Figure 5. Pre-treatment of the RL95-2 cells with AP-1 inhibitor restored the TLR 783 
3-induced reduction of JAr spheroid adhesion.  784 
RL95-2 cells were pre-treated with Bay11- ? ? ? ? ? ? ?ʅD ?ĂŶĚ^W ? ? ? ? ? ? ? ? ?ʅD ?ĨŽƌ ?Ś ?dŚĞ785 
cells were stimulated with TLR 3 ůŝŐĂŶĚ ? ? ?ʅŐ ?ŵůWŽůǇ/ P ?ĨŽƌ ?Ś ? ? ?:ƌƐƉŚĞƌŽŝĚƐǁ ƌĞƚŚĞŶ786 
delivered and co-cultured with the endometrial cells for 1 h. The plate was rinsed and the 787 
results are expressed as the percentage of attached spheroids. The experiments were 788 
performed in three replicates on three separate days. The data are the average of three 789 
independent experiments. The results were presented as the mean ± SEM. ANOVA was used 790 
to compare the percentage of the attached spheroids in each group. Different letters denote 791 
significant differences. P < 0.05 was considered to be significant. 792 
 793 
Figure 6. A mechanistic pathway of TLR 3-induced impairment of trophoblast 794 
adhesion to endometrial cells.  795 
A schematic demonstration of TLR 3 signalling pathway, showing the potential involvement 796 
of mitogen-activated protein kinases (MAPK) pathway in TLR 3-induced IL-1RA production, 797 
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ĂůƚĞƌĂƚŝŽŶŝŶĐĞůůĐǇƚŽƐŬĞůĞƚŽŶ ?ƐĂƌƌĂŶŐĞŵĞŶƚĂŶĚĞǆƉƌĞƐƐŝŽŶŽĨĂĚŚĞƐŝŽŶŵŽůĞĐƵůĞƐ (cluster 798 
of differentiation (CD98) and beta3 integrin), which in turn leads to inhibition of trophoblast 799 
cells ?ĂĚŚĞƐŝŽŶƚŽĞŶĚŽmetrial cell (Montazeri et al., 2015).  800 
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